BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 16253726)

  • 21. Can we predict when to start renal replacement therapy in patients with chronic kidney disease using 6 months of clinical data?
    Lee MJ; Park JH; Moon YR; Jo SY; Yoon D; Park RW; Jeong JC; Park I; Shin GT; Kim H
    PLoS One; 2018; 13(10):e0204586. PubMed ID: 30286208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mortality and Low Serum Bicarbonate Level in Patients on Hemodiafiltration versus Peritoneal Dialysis.
    Raikou VD; Kyriaki D
    Indian J Nephrol; 2018; 28(2):105-112. PubMed ID: 29861560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk Factors for Prognosis in Patients With Severely Decreased GFR.
    Evans M; Grams ME; Sang Y; Astor BC; Blankestijn PJ; Brunskill NJ; Collins JF; Kalra PA; Kovesdy CP; Levin A; Mark PB; Moranne O; Rao P; Rios PG; Schneider MP; Shalev V; Zhang H; Chang AR; Gansevoort RT; Matsushita K; Zhang L; Eckardt KU; Hemmelgarn B; Wheeler DC
    Kidney Int Rep; 2018 May; 3(3):625-637. PubMed ID: 29854970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glycine N-methyltransferase inhibits aristolochic acid nephropathy by increasing CYP3A44 and decreasing NQO1 expression in female mouse hepatocytes.
    Chang MM; Lin CN; Fang CC; Chen M; Liang PI; Li WM; Yeh BW; Cheng HC; Huang BM; Wu WJ; Chen YA
    Sci Rep; 2018 May; 8(1):6960. PubMed ID: 29725048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease.
    Carrero JJ; Hecking M; Chesnaye NC; Jager KJ
    Nat Rev Nephrol; 2018 Mar; 14(3):151-164. PubMed ID: 29355169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination therapy of exendin-4 and allogenic adipose-derived mesenchymal stem cell preserved renal function in a chronic kidney disease and sepsis syndrome setting in rats.
    Chen CH; Cheng BC; Chen KH; Shao PL; Sung PH; Chiang HJ; Yang CC; Lin KC; Sun CK; Sheu JJ; Chang HW; Lee MS; Yip HK
    Oncotarget; 2017 Nov; 8(59):100002-100020. PubMed ID: 29245956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gender Differences in the Acute Kidney Injury to Chronic Kidney Disease Transition.
    Lima-Posada I; Portas-Cortés C; Pérez-Villalva R; Fontana F; Rodríguez-Romo R; Prieto R; Sánchez-Navarro A; Rodríguez-González GL; Gamba G; Zambrano E; Bobadilla NA
    Sci Rep; 2017 Sep; 7(1):12270. PubMed ID: 28947737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Body shape index: Sex-specific differences in predictive power for all-cause mortality in the Japanese population.
    Sato Y; Fujimoto S; Konta T; Iseki K; Moriyama T; Yamagata K; Tsuruya K; Narita I; Kondo M; Kasahara M; Shibagaki Y; Asahi K; Watanabe T
    PLoS One; 2017; 12(5):e0177779. PubMed ID: 28520811
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Physical Exercise and Patients with Chronic Renal Failure: A Meta-Analysis.
    Qiu Z; Zheng K; Zhang H; Feng J; Wang L; Zhou H
    Biomed Res Int; 2017; 2017():7191826. PubMed ID: 28316986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence and risk factors for cardiovascular disease among chronic kidney disease patients: results from the Chinese cohort study of chronic kidney disease (C-STRIDE).
    Yuan J; Zou XR; Han SP; Cheng H; Wang L; Wang JW; Zhang LX; Zhao MH; Wang XQ;
    BMC Nephrol; 2017 Jan; 18(1):23. PubMed ID: 28088175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Underweight Is an Independent Risk Factor for Renal Function Deterioration in Patients with IgA Nephropathy.
    Ouyang Y; Xie J; Yang M; Zhang X; Ren H; Wang W; Chen N
    PLoS One; 2016; 11(9):e0162044. PubMed ID: 27611091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of anthropometric measures with kidney disease progression and mortality: a retrospective cohort study of pre-dialysis chronic kidney disease patients referred to a specialist renal service.
    Davis E; Campbell K; Gobe G; Hawley C; Isbel N; Johnson DW
    BMC Nephrol; 2016 Jul; 17(1):74. PubMed ID: 27391644
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of proteinuria and glomerular filtration rate on Taiwanese patients with diabetes mellitus and advanced chronic kidney disease: a single center experience.
    Chen PM; Wada T; Chiang CK
    Clin Exp Nephrol; 2017 Apr; 21(2):307-315. PubMed ID: 27339442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The dual roles of obesity in chronic kidney disease: a review of the current literature.
    Rhee CM; Ahmadi SF; Kalantar-Zadeh K
    Curr Opin Nephrol Hypertens; 2016 May; 25(3):208-16. PubMed ID: 26999023
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk Factors for Development and Progression of Chronic Kidney Disease: A Systematic Review and Exploratory Meta-Analysis.
    Tsai WC; Wu HY; Peng YS; Ko MJ; Wu MS; Hung KY; Wu KD; Chu TS; Chien KL
    Medicine (Baltimore); 2016 Mar; 95(11):e3013. PubMed ID: 26986114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Envy of Scholars: Applying the Lessons of the Framingham Heart Study to the Prevention of Chronic Kidney Disease.
    Wasser WG; Gil A; Skorecki KL
    Rambam Maimonides Med J; 2015 Jul; 6(3):. PubMed ID: 26241225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic kidney disease.
    Clase CM; Smyth A
    BMJ Clin Evid; 2015 Jun; 2015():. PubMed ID: 26121377
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Body mass index, mortality, and gender difference in advanced chronic kidney disease.
    Huang JC; Lin HY; Lim LM; Chen SC; Chang JM; Hwang SJ; Tsai JC; Hung CC; Chen HC
    PLoS One; 2015; 10(5):e0126668. PubMed ID: 25942584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estimating time to ESRD using kidney failure risk equations: results from the African American Study of Kidney Disease and Hypertension (AASK).
    Grams ME; Li L; Greene TH; Tin A; Sang Y; Kao WH; Lipkowitz MS; Wright JT; Chang AR; Astor BC; Appel LJ
    Am J Kidney Dis; 2015 Mar; 65(3):394-402. PubMed ID: 25441435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endogenous female sex hormones delay the development of renal dysfunction in apolipoprotein E-deficient mice.
    Carneiro SS; Carminati RZ; Freitas FP; Podratz PL; Balarini CM; Graceli JB; Meyrelles SS; Vasquez EC; Gava AL
    Lipids Health Dis; 2014 Nov; 13():176. PubMed ID: 25422135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.